Topic

Tegsedi (inotersen)

A collection of 37 issues

How Long Does It Take to Get Tegsedi (Inotersen) Approved by UnitedHealthcare in Illinois? Complete Timeline & Appeals Guide

Answer Box: Getting Tegsedi Approved by UnitedHealthcare in Illinois Timeline: 3-15 business days for standard prior authorization once all documentation is complete. UnitedHealthcare requires prior authorization for Tegsedi (inotersen) with specific criteria for hATTR polyneuropathy. First step today: Verify your plan coverage at myuhc.com and ensure REMS enrollment is

How to Get Tegsedi (Inotersen) Covered by Humana in Virginia: Complete Appeal Guide with Forms and Timelines

Answer Box: Getting Tegsedi (Inotersen) Covered by Humana in Virginia Tegsedi (inotersen) requires prior authorization from Humana Medicare Advantage and Part D plans. The fastest path to approval involves three key steps: (1) Ensure your prescriber enrolls in the FDA's Tegsedi REMS program and submits baseline lab results,

How to Get Tegsedi (Inotersen) Covered by Humana in Washington: Prior Authorization, Appeals, and Cost Assistance

Answer Box: Getting Tegsedi (Inotersen) Covered by Humana in Washington Note: Tegsedi was discontinued in September 2024 - verify current availability before proceeding. Getting Tegsedi covered by Humana requires prior authorization with specific documentation: genetic confirmation of hATTR polyneuropathy, specialist prescription, REMS enrollment, and baseline labs. In Washington, if denied,

How to Get Tegsedi (inotersen) Covered by Cigna in California: Complete Guide with Forms, Appeals, and IMR Process

Answer Box: Your Fastest Path to Tegsedi Coverage Tegsedi (inotersen) requires prior authorization through Cigna in California. Your prescriber must submit a PA request via the EviCore portal or call 1-800-882-4462 with genetic testing confirmation, REMS enrollment proof, and specialist prescription. If denied, file an internal appeal within 180 days,

How to Get Tegsedi (Inotersen) Covered by Cigna in Washington: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Tegsedi (Inotersen) Approved by Cigna in Washington Cigna requires prior authorization for Tegsedi (inotersen) with strict criteria: confirmed hATTR polyneuropathy, TTR gene mutation, REMS enrollment, and detailed lab monitoring plan. In Washington, you have 72 hours for standard PA decisions and strong appeal rights including independent external

How to Get Tegsedi (inotersen) Covered by Aetna (CVS Health) in Washington: Complete Prior Authorization Guide

Answer Box: Getting Tegsedi (inotersen) Covered by Aetna (CVS Health) in Washington Aetna (CVS Health) requires prior authorization for Tegsedi (inotersen) with specific documentation: TTR gene mutation testing, specialist prescription, and FDA REMS enrollment. Submit via Availity portal or fax (866-752-7021) at least 2 weeks before treatment. If denied, Washington

How to Get Tegsedi (Inotersen) Covered by Cigna in Georgia: Complete Prior Authorization and Appeals Guide

Quick Answer: To get Tegsedi (inotersen) covered by Cigna in Georgia, you need: (1) genetic confirmation of hATTR polyneuropathy, (2) REMS enrollment for prescriber and patient, (3) prior authorization with baseline labs and monitoring plan, and (4) specialty pharmacy routing through Accredo. If denied, Georgia law gives you 60 days

How to Get Tegsedi (inotersen) Covered by Cigna in Michigan: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tegsedi (inotersen) Covered by Cigna in Michigan Tegsedi (inotersen) for hATTR polyneuropathy requires prior authorization from Cigna through Express Scripts, REMS program enrollment, and specialty pharmacy dispensing via Accredo. Michigan patients have strong appeal rights through DIFS external review (127 days to file after final denial). Start

Coding That Helps Get Tegsedi (inotersen) Approved by Cigna in Florida: ICD-10, HCPCS/J-Code, and NDC Guide

Answer Box: Getting Tegsedi (inotersen) Coded Correctly for Cigna Coverage in Florida Fastest path to approval: Use ICD-10 code E85.1 (neuropathic heredofamilial amyloidosis), HCPCS J3490 (unclassified drugs) with NDC 72126-0007-02, and submit via Cigna's electronic PA system through Express Scripts/Accredo. Tegsedi requires prior authorization under the

How to Get Tegsedi (Inotersen) Covered by Aetna CVS Health in Illinois: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tegsedi (Inotersen) Covered by Aetna CVS Health in Illinois Tegsedi (inotersen) requires prior authorization from Aetna CVS Health for hATTR polyneuropathy coverage in Illinois. Key requirements: confirmed TTR gene mutation, documented polyneuropathy symptoms, specialist prescription (neurologist/geneticist), and REMS program enrollment. Submit via Aetna provider portal with